Study S002058

Estimating the Impact of Obesity Medications on Clinical and Economic Outcomes

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT07640139
Study type: OBSERVATIONAL
Status: ENROLLING_BY_INVITATION
Enrollment: 125000
Start: 2026-01-01
Primary completion: 2029-12-31
Lead sponsor: Indiana University
Conditions: Obesity
Interventions: DRUG:Incretin-based therapies (GLP-1 and GLP-1/GIP)
Results posted: FALSE
Individual participant data sharing: NO
Secondary identifiers: OTHER:26469

Registered primary outcomes

Change in subject body weight. [6 months periods from 2018 to 2029]
Change in subject body mass index (BMI). [6 months periods from 2018 to 2029]
Change in obesity and overweight classification. [6 months periods from 2018 to 2029]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.